Vanguard Group Inc Journey Medical Corp Transaction History
Vanguard Group Inc
- $5.97 Trillion
- Q2 2025
A detailed history of Vanguard Group Inc transactions in Journey Medical Corp stock. As of the latest transaction made, Vanguard Group Inc holds 564,988 shares of DERM stock, worth $4.15 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
564,988
Previous 372,261
51.77%
Holding current value
$4.15 Million
Previous $2.2 Million
84.7%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding DERM
# of Institutions
62Shares Held
7MCall Options Held
0Put Options Held
0-
Tang Capital Management LLC San Diego, CA1.85MShares$13.6 Million0.8% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT1.15MShares$8.47 Million0.04% of portfolio
-
B. Riley Securities, Inc. Los Angeles, CA865KShares$6.36 Million0.36% of portfolio
-
Geode Capital Management, LLC Boston, MA262KShares$1.93 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny244KShares$1.79 Million0.0% of portfolio
About Journey Medical Corp
- Ticker DERM
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 11,596,500
- Market Cap $85.2M
- Description
- Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat...